B. Gansbacher

Publication List Details

Period

1994 - 2002

Number

6

Co-Authors

Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model (2002)

Arlt,M., Kopitz,C., Pennington,C., Watson,K. L. M., Krell,H. W., Bode,W., ...

The recognition that matrix metalloproteinases (MMPs) facilitate tumor cell invasion and metastasis has led to the development of synthetic MMP inhibitors (MMPIs) as cancer therapeutic agents....

Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model (2002)

Arlt, M., Kopitz, C., Pennington, C., Watson, K. L. M., Krell, H. W., Bode, W., ...

The recognition that matrix metalloproteinases (MMPs) facilitate tumor cell invasion and metastasis has led to the development of synthetic MMP inhibitors (MMPIs) as cancer therapeutic agents....

Effect of PHA-activated T cells on B-cell differentiation.

Gansbacher, B, Levinson, A I

Recent studies indicate that human T cells expressing the T4 determinant are comprised of functionally distinct subsets. We investigated if activation of OKT4+ cells with the mitogen PHA affected...

HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.

Gansbacher, B, Zier, K S

The expression of HLA Class II beta genes by seven CD4- or CD8-positive T cell clones grown in conditioned medium was examined on the mRNA and cell surface levels. Monoclonal antibodies directed...

IL2 treatment for cancer: from biology to gene therapy.

Foa, R., Guarini, A., Gansbacher, B.

In this review we shall discuss the biological rationale and the clinical findings obtained using Interleukin 2 (IL2)-based immunotherapy in the management of cancer patients. Objective and...